Elsevier

Brain Research

Volume 1045, Issues 1–2, 31 May 2005, Pages 57-63
Brain Research

Research report
HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells

https://doi.org/10.1016/j.brainres.2005.03.031Get rights and content

Abstract

The blood–brain barrier (BBB) has an important role in the development of AIDS dementia. The HIV-1 envelope glycoprotein (gp120) and transregulatory protein (Tat) of HIV-1 are neurotoxic and cytotoxic and have been implicated in the development of HIV dementia. They are known to cause oxidative stress and are associated with disruption of the BBB. Here, we used an immortalized endothelial cell line from rat brain capillaries, RBE4, to determine whether gp120 and Tat can induce oxidative stress in an in vitro model of the BBB. RBE4 cells were exposed to gp120 or Tat and the levels of reduced glutathione (GSH), oxidized glutathione (GSSG), catalase (CAT) activity, glutathione peroxidase (GPx) activity, and glutathione reductase (GR) activity, and malondialdehyde (MDA) used as measures of oxidative stress. Both gp120 and Tat significantly decreased the levels of intracellular GSH, GPx, and GR and increased the levels of MDA in RBE4 cells, showing that the cells were oxidatively challenged. The ratio of GSH/GSSG, a widely accepted indicator of oxidative stress, was also significantly decreased. These studies show that both of these viral proteins can induce oxidative stress in immortalized BBB endothelial cells.

Introduction

AIDS is often accompanied by neurological disorders and neuropathological abnormalities. A third of the adults and half of the children with AIDS develop HIV-1-associated dementia (HAD) [23]. Cognitive impairment, postural disorders, and tremors are among the most common symptoms encountered in patients suffering from AIDS dementia complex [12]. The role of the blood–brain barrier (BBB) is important in the development of HIV dementia because it serves as the conduit by which free virus and infected immune cells enter the brain from the circulatory system [8], [25], [27]. It also prevents the effective accumulation of many anti-retrovirals in the brain [9], [35] and releases substances in response to immunological (including viral) challenges [7], [14], [20], [22], [26], [31]. A mild disruption of the BBB is more frequent in AIDS patients with dementia, as compared with AIDS patients without dementia or sero-negative controls [36], and such problems may be related to the trafficking of immune cells across the BBB [5]. The BBB is composed of a continuous layer of cerebrovascular endothelial cells connected by intercellular tight junctions. This barrier exists between blood and brain interstitial fluid and tightly regulates the entry of compounds into the brain. The BBB helps to maintain the homeostatic environment of the brain, supplies the brain's nutritive needs, and plays a role in communication between the brain and peripheral tissues [6], [13], [18], [19], [30], [33]. Under physiological conditions, the integrity of the BBB is protected from oxidative stress because the BBB has high levels of antioxidant enzymes. These peroxide detoxifying enzymes play an important role in protecting the functional integrity of the BBB, which is essential for proper functioning of the brain [28].

In the last few years, there has been a body of evidence that HIV-1 envelope protein gp120 or Tat (trans-activator of viral replication) may cause BBB changes. There is a possibility that the binding of these proteins to brain endothelial cells may cause many of the changes seen in the BBB in HIV-dementia patients [4]. For example, one study found a significant increase in permeability (up to 47%) in cultured endothelial cells after exposure to gp120 [11]. Another study confirmed that gp120 is capable of changing and activating the vascular component of the BBB in vivo [37]. Yet another study on HIV-1 Tat protein demonstrated that exposure of endothelial cells to HIV-1 Tat protein resulted in a dose-dependent increase in oxidative stress and a decrease in intracellular glutathione (GSH) [36].

GSH, which is an important intracellular non-protein thiol compound in mammalian cells, has a pivotal role in the maintenance of membrane integrity. It may also play an important role in the proper functioning of the BBB [2]. Although brain endothelial cells posses high intracellular levels of antioxidative defense mechanisms, such as GSH, GSH peroxidase (GPx), and catalase (CAT), exposure to toxins and drugs may render the BBB susceptible to toxic damage and change its specific functions [21].

This present study concentrates on the oxidative stress induced in vitro in an immortalized cell line of rat brain endothelial cells, RBE4 cells, when exposed to the HIV-1 proteins gp120 and Tat. Previous studies only investigated limited oxidative stress parameters. Therefore, in this study, we have included the most widely used parameters.

Section snippets

Reagents and chemicals

Acetonitrile, acetic acid, water, and phosphoric acid (all HPLC grade) were purchased from Fisher (St. Louis, MO). All other chemicals were obtained from Sigma (St. Louis, MO). N-(1-pyrenyl)-maleimide (NPM) was purchased from Aldrich (Milwaukee, WI, USA).

HIV-1 proteins

The recombinant HIV-1 proteins gp120 (HIVSF2gp120) and Tat were obtained from The National Institutes of Health (NIH) AIDS Reagent Program (Rockville, MD).

HPLC system

The HPLC System (Shimadzu) consisted of a model LC-10A pump, an autoinjector with a

Glutathione levels and GSH/GSSG ratios

Fig. 1 shows the dose-dependent effects of gp120 or Tat on cellular GSH levels in RBE4 cells, as measured by HPLC. A 2-h exposure to gp120 or Tat resulted in a marked increase in cellular oxidative stress. Treatment with 1 μg or 2 μg gp120 or 1 μg Tat resulted in a decrease in cellular GSH levels, as compared with the control group. Heat inactivated gp120 and Tat did not affect GSH levels.

As shown in Fig. 2, exposure for 2 h to 1 μg or 2 μg gp120 or 1 μg Tat decreased cellular glutathione

Discussion

Free radical production and oxidative stress play an important role in the pathogenesis of different neurodegenerative disorders, including HIV-associated dementia. The mechanism by which HIV-1 proteins induce oxidative stress is not completely known. One proposed mechanism is that HIV-1-induced neurotoxicity may be due to an increased production of reactive oxygen species (ROS) by HIV-1 proteins (gp120 and Tat). The pathogenesis of HIV-1 infection has implicated increased levels of ROS.

Acknowledgments

The authors would like to thank Dr. Roux for providing RBE4 cells, Kathy Wolf for her generous help on assistance, and Barbara Harris for her carefully editing of our manuscript. This study was supported by VA Merit Review, RO1 NS41863, and the NIH AIDS Reagent program (gp120 and Tat).

References (38)

  • T.M. Reyes et al.

    Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli

    Brain Res.

    (1999)
  • R. Winters et al.

    Analysis of glutathione, glutathione disulfide, cysteine, homocysteine, and other biological thiols by HPLC following derivatization with N-(1-pyrenyl) maleimide

    Anal. Biochem.

    (1995)
  • R. Agarwal et al.

    Potential role of cerebral glutathione in the maintenance of blood–brain barrier integrity in rat

    Neurochem. Res.

    (1999)
  • P. Annunziata

    Blood–brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism

    J. Neurol.

    (2003)
  • M.J. Avison et al.

    Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia

    J. Neurovirol.

    (2004)
  • W.A. Banks

    Physiology and pathophysiology of the blood–brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders

    J. Neurovirol.

    (1999)
  • W.A. Banks

    Protector, prey, or perpetrator: the pathophysiology of the blood–brain barrier in NeuroAIDS, science online

    NeuroAIDS

    (2000)
  • W.A. Banks et al.

    Transport of human immunodeficiency virus type 1 pseudoviruses across the blood–brain barrier: role of envelope proteins and adsorptive endocytosis

    J. Virol.

    (2001)
  • D.J. Begley

    ABC transporters and the blood–brain barrier

    Curr. Pharm. Des.

    (2004)
  • Cited by (163)

    • HIV-associated neurotoxicity and cognitive decline: Therapeutic implications

      2022, Pharmacology and Therapeutics
      Citation Excerpt :

      The use of the SV40 vector system appears to accurately reflect in vivo conditions. Elevation in oxidative stress has been reported with Tat (Aksenov et al., 2001, 2003; Jean-Pierre Louboutin & Strayer, 2014; Pocernich, Sultana, Mohmmad-Abdul, Nath, & Butterfield, 2005; Price et al., 2005; Wallace et al., 2006). Increased oxidative stress may affect normal mitochondrial function (Rozzi et al., 2017).

    View all citing articles on Scopus
    View full text